<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Amino Acids</journal-id><journal-id journal-id-type="iso-abbrev">Amino Acids</journal-id><journal-title-group><journal-title>Amino Acids</journal-title></journal-title-group><issn pub-type="ppub">0939-4451</issn><issn pub-type="epub">1438-2199</issn><publisher><publisher-name>Springer Vienna</publisher-name><publisher-loc>Vienna</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22143432</article-id><article-id pub-id-type="pmc">3374124</article-id><article-id pub-id-type="publisher-id">1190</article-id><article-id pub-id-type="doi">10.1007/s00726-011-1190-x</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Beta-alanine (Carnosyn&#x02122;) supplementation in elderly subjects (60&#x02013;80&#x000a0;years): effects on muscle carnosine content and physical capacity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>del Favero</surname><given-names>Serena</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Roschel</surname><given-names>Hamilton</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Solis</surname><given-names>Marina Y.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hayashi</surname><given-names>Ana P.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Artioli</surname><given-names>Guilherme G.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Otaduy</surname><given-names>Maria Concepci&#x000f3;n</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Benatti</surname><given-names>Fabiana B.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Harris</surname><given-names>Roger C.</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Wise</surname><given-names>John A.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Leite</surname><given-names>Cl&#x000e1;udia C.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Pereira</surname><given-names>Rosa M.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>de S&#x000e1;-Pinto</surname><given-names>Ana L.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Lancha-Junior</surname><given-names>Antonio Herbert</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Gualano</surname><given-names>Bruno</given-names></name><address><phone>+55-11-30913096</phone><fax>+55-11-38135921</fax><email>gualano@usp.br</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label>School of Physical Education and Sport, University of Sao Paulo, Av Mello de Moraes, 65, Butant&#x000e3;, Sao Paulo, SP 05508-030 Brazil </aff><aff id="Aff2"><label>2</label>Division of Radiology, School of Medicine, University of Sao Paulo, Sao Paulo, Brazil </aff><aff id="Aff3"><label>3</label>Junipa Ltd, Newmarket, Suffolk, UK </aff><aff id="Aff4"><label>4</label>Natural Alternatives International Inc, San Marcos, USA </aff><aff id="Aff5"><label>5</label>Division of Rheumatology, School of Medicine, University of Sao Paulo, Sao Paulo, Brazil </aff></contrib-group><pub-date pub-type="epub"><day>6</day><month>12</month><year>2011</year></pub-date><pub-date pub-type="pmc-release"><day>6</day><month>12</month><year>2011</year></pub-date><pub-date pub-type="ppub"><month>7</month><year>2012</year></pub-date><volume>43</volume><issue>1</issue><fpage>49</fpage><lpage>56</lpage><history><date date-type="received"><day>22</day><month>9</month><year>2011</year></date><date date-type="accepted"><day>29</day><month>11</month><year>2011</year></date></history><permissions><copyright-statement>&#x000a9; Springer-Verlag 2011</copyright-statement></permissions><abstract id="Abs1"><p>The aim of this study was to investigate the effects of beta-alanine supplementation on exercise capacity and the muscle carnosine content in elderly subjects. Eighteen healthy elderly subjects (60&#x02013;80&#x000a0;years, 10 female and 4 male) were randomly assigned to receive either beta-alanine (BA, <italic>n</italic>&#x000a0;=&#x000a0;12) or placebo (PL, <italic>n</italic>&#x000a0;=&#x000a0;6) for 12&#x000a0;weeks. The BA group received 3.2&#x000a0;g of beta-alanine per day (2&#x000a0;&#x000d7;&#x000a0;800&#x000a0;mg sustained-release Carnosyn&#x02122; tablets, given 2 times per day). The PL group received 2&#x000a0;&#x000d7;&#x000a0;(2&#x000a0;&#x000d7;&#x000a0;800&#x000a0;mg) of a matched placebo. At baseline (PRE) and after 12&#x000a0;weeks (POST-12) of supplementation, assessments were made of the muscle carnosine content, anaerobic exercise capacity, muscle function, quality of life, physical activity and food intake. A significant increase in the muscle carnosine content of the gastrocnemius muscle was shown in the BA group (+85.4%) when compared with the PL group (+7.2%) (<italic>p</italic>&#x000a0;=&#x000a0;0.004; ES: 1.21). The time-to-exhaustion in the constant-load submaximal test (i.e., TLIM) was significantly improved (<italic>p</italic>&#x000a0;=&#x000a0;0.05; ES: 1.71) in the BA group (+36.5%) versus the PL group (+8.6%). Similarly, time-to-exhaustion in the incremental test was also significantly increased (<italic>p</italic>&#x000a0;=&#x000a0;0.04; ES 1.03) following beta-alanine supplementation (+12.2%) when compared with placebo (+0.1%). Significant positive correlations were also shown between the relative change in the muscle carnosine content and the relative change in the time-to-exhaustion in the TLIM test (<italic>r</italic>&#x000a0;=&#x000a0;0.62; <italic>p</italic>&#x000a0;=&#x000a0;0.01) and in the incremental test (<italic>r</italic>&#x000a0;=&#x000a0;0.48; <italic>p</italic>&#x000a0;=&#x000a0;0.02). In summary, the current data indicate for the first time, that beta-alanine supplementation is effective in increasing the muscle carnosine content in healthy elderly subjects, with subsequent improvement in their exercise capacity.</p></abstract><kwd-group><title>Keywords</title><kwd>Acidosis</kwd><kwd>Buffering capacity</kwd><kwd>Ergogenic aid</kwd><kwd>Elderly people</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag 2012</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>Ageing is associated with both a loss of skeletal muscle mass and skeletal muscle function leading to varying degrees of sarcopenia as defined by the European Working Group on Sarcopenia in Older People (EWGSOP) (Cruz-Jentoft et al. <xref ref-type="bibr" rid="CR7">2010</xref>). Changes include a decrease in the cross sectional area of type II muscle fibres (Verdijk et al. <xref ref-type="bibr" rid="CR31">2010</xref>) as well as a loss of both type I and II muscle fibres (Doherty <xref ref-type="bibr" rid="CR8">2003</xref>), and a replacement of fibres with fat. Ageing is also associated with a significant reduction in skeletal muscle carnosine (Stuerenburg and Kunze <xref ref-type="bibr" rid="CR27">1999</xref>; Tallon et al. <xref ref-type="bibr" rid="CR28">2007</xref>) resulting in a decline in the buffering capacity of the muscle. As a result elderly subjects may experience a decrease in their capacity to undertake anaerobic activity where this is limited by intramuscular cell pH decrease (Stout et al. <xref ref-type="bibr" rid="CR26">2008</xref>). Combined with the loss in muscle mass, progressive changes in muscle function will contribute to an increased sense of frailty in elderly men and women with impairments in balance, gait speed, and an increased risk of falls (Madureira et al. <xref ref-type="bibr" rid="CR17">2010</xref>). With the increase in longevity of industrialized populations, sarcopenia is emerging as a major health and financial concern at the national level. Regular exercise, incorporating some form of resistance training, is considered one of the most effective measures to slow, and even reverse the progression of sarcopenia (Snijders et al. <xref ref-type="bibr" rid="CR23">2009</xref>; Verdijk et al. <xref ref-type="bibr" rid="CR29">2009a</xref>, <xref ref-type="bibr" rid="CR30">b</xref>).</p><p>Carnosine is a dipeptide synthesized in muscle and other tissues involved in intracellular buffering and is composed of the two amino acids histidine and beta-alanine (Artioli et al. <xref ref-type="bibr" rid="CR1">2010</xref>). The availability of the is limiting to the in vivo synthesis of carnosine under normal physiological conditions (Harris et al. <xref ref-type="bibr" rid="CR11">2006</xref>). It has been previously shown that supplementation with beta-alanine has the potential to increase muscle carnosine content by 60&#x02013;80% in healthy young adults, and that this is accompanied by an improvement in the ability to perform high-intensity exercise (Harris et al. <xref ref-type="bibr" rid="CR11">2006</xref>; Hill et al. <xref ref-type="bibr" rid="CR12">2007</xref>; Kendrick et al. <xref ref-type="bibr" rid="CR14">2008</xref>, <xref ref-type="bibr" rid="CR15">2009</xref>).</p><p>Improving the buffering capacity of muscle could be important for muscle function and daily-life activities in the elderly. A previous study (Stout et al. <xref ref-type="bibr" rid="CR26">2008</xref>) demonstrated a 28.6% increase in the physical working capacity at the neuromuscular fatigue threshold after 90&#x000a0;days of beta-alanine supplementation (3&#x000a0;&#x000d7;&#x000a0;800&#x000a0;mg/day) in men and women aged 55&#x02013;92&#x000a0;years. The authors suggested that the increase in working capacity could have importance in the prevention of falls, and the maintenance of health and independent living of elderly men and women. However, the authors did not assess muscle carnosine content. In fact, to the best of our knowledge, no study has directly investigated the effect of beta-alanine supplementation on the muscle carnosine content in elderly individuals. It remains to be seen if (a) muscle increases in carnosine can be achieved to a similar extent as has been reported in younger subjects, and (b) if any such increases can be correlated with changes in exercise capacity.</p><p>Therefore, the aim of this study was to investigate the effects of beta-alanine supplementation on exercise performance capacity and the muscle carnosine content in elderly subjects. It was hypothesized that beta-alanine supplementation would increase the muscle carnosine content in the elderly, which would be paralleled by an increase in exercise capacity.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Subjects</title><p>Eighteen subjects (60&#x02013;80&#x000a0;years) who had not engaged in any exercise programme for at least 1&#x000a0;year were recruited to the study. Exclusion criteria were assessed by a physician and were as follows: joint disease or other causes of limited mobility that would prevent the subject undertaking the exercise tests, cardiovascular diseases which had not been treated, the use of nutritional supplements within the past 6&#x000a0;months (e.g., protein, amino acids and creatine), and the use of any drug that could induce myopathy (e.g., simvastatin, glucocorticoid). Volunteers were instructed to refrain from any exercise-training programme during the course of the study.</p><p>The Local Ethical Committee approved the study and all subjects gave their consent in writing after the purpose of the study and the risks involved had been explained.</p></sec><sec id="Sec4"><title>Experimental protocol</title><p>A double-blind, placebo-controlled study was conducted between October 2010 and May 2011 in Sao Paulo (Brazil).</p><p>Each participant was randomly assigned to either the beta-alanine (BA, <italic>n</italic>&#x000a0;=&#x000a0;12) or placebo (PL, <italic>n</italic>&#x000a0;=&#x000a0;6) group using a computer-generated randomization code. An unbalanced design was adopted a priori to reduce the cost of the trial and to gain more experience in using beta-alanine supplementation in elderly subjects. The BA group received 3.2&#x000a0;g of beta-alanine per day (2&#x000a0;&#x000d7;&#x000a0;800&#x000a0;mg sustained-release Carnosyn&#x02122; tablets, given 2 times per day after lunch and dinner). The PL group received 2&#x000a0;&#x000d7;&#x000a0;(2&#x000a0;&#x000d7;&#x000a0;800&#x000a0;mg) placebo made up of maltodextrin, which was identical in appearance. The supplements were obtained from Natural Alternatives International, San Marcos, USA. Carnosyn&#x02122; and placebo tablets were from the same batch as used by Sale et al. (<xref ref-type="bibr" rid="CR22">2011</xref>) and were tested by HFL Sports Science (Newmarket, UK) before use to ensure no contamination with steroids or stimulants according to ISO 17025-accredited tests. A researcher called the subjects on daily basis to verify the compliance to supplementation intake.</p><p>Muscle carnosine, anaerobic exercise capacity, muscle function and quality of life were assessed at baseline (PRE) and after 12&#x000a0;weeks (POST-12) of supplementation. All of the subjects underwent one familiarization session prior to the muscle function tests. Food intake was assessed at baseline and after the intervention and physical activity levels were assessed only at baseline. The closer monitoring of physical activity patterns and diet was not possible and it is a limitation of this study.</p><p>All the subjects were physically inactive (as assessed by the international physical activity questionnaire&#x02014;IPAQ) (Voorrips et al. <xref ref-type="bibr" rid="CR32">1991</xref>) and well nourished (as assessed by the Mini Nutritional Assessment (MNA) (Guigoz et al. <xref ref-type="bibr" rid="CR9">1994</xref>) at baseline and after the intervention. To characterize the sample, measurements of body composition were also assessed at PRE and POST-12 by Dual-energy X-ray absorptiometry (DXA, Hologic QDR 4500, Discovery model Bedford, MA, USA). Subjects&#x02019; demographic characteristics are given in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Subjects&#x02019; demographic characteristics at baseline</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Beta-alanine (<italic>n</italic>&#x000a0;=&#x000a0;12)</th><th align="left">Placebo (<italic>n</italic>&#x000a0;=&#x000a0;6)</th></tr></thead><tbody><tr><td align="left">Gender (M/F)</td><td align="left">6/6</td><td align="left">2/4</td></tr><tr><td align="left">Age (years)</td><td align="left">65&#x000a0;&#x000b1;&#x000a0;4</td><td align="left">64&#x000a0;&#x000b1;&#x000a0;7</td></tr><tr><td align="left">Height (cm)</td><td align="left">162&#x000a0;&#x000b1;&#x000a0;11</td><td align="left">162&#x000a0;&#x000b1;&#x000a0;5</td></tr><tr><td align="left">Body mass&#x000a0;(kg)</td><td align="left">78.2&#x000a0;&#x000b1;&#x000a0;11.8</td><td align="left">74.7&#x000a0;&#x000b1;&#x000a0;12.4</td></tr><tr><td align="left">BMI&#x000a0;(kg/cm<sup>2</sup>)</td><td align="left">29.6&#x000a0;&#x000b1;&#x000a0;2.7</td><td align="left">28.4&#x000a0;&#x000b1;&#x000a0;4.3</td></tr><tr><td align="left">Body fat&#x000a0;(kg)</td><td align="left">25.9&#x000a0;&#x000b1;&#x000a0;4.1</td><td align="left">26.1&#x000a0;&#x000b1;&#x000a0;6.8</td></tr><tr><td align="left">Body fat&#x000a0;(%)</td><td align="left">33.4&#x000a0;&#x000b1;&#x000a0;5.2</td><td align="left">34.8&#x000a0;&#x000b1;&#x000a0;8.2</td></tr><tr><td align="left">LBM&#x000a0;(kg)</td><td align="left">50.1&#x000a0;&#x000b1;&#x000a0;9.7</td><td align="left">47.1&#x000a0;&#x000b1;&#x000a0;10.1</td></tr><tr><td align="left">BMD&#x000a0;(g/cm<sup>2</sup>)</td><td align="left">1.1&#x000a0;&#x000b1;&#x000a0;0.1</td><td align="left">1.0&#x000a0;&#x000b1;&#x000a0;0.1</td></tr><tr><td align="left">BMC&#x000a0;(kg)</td><td align="left">2.1&#x000a0;&#x000b1;&#x000a0;0.4</td><td align="left">2.0&#x000a0;&#x000b1;&#x000a0;0.2</td></tr></tbody></table><table-wrap-foot><p>Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD. There were no significant differences between groups at baseline (<italic>p</italic>&#x000a0;&#x0003e;&#x000a0;0.05)</p><p><italic>M</italic>&#x000a0;males, <italic>F</italic>&#x000a0;females, <italic>BMI</italic>&#x000a0;body mass index, <italic>LBM</italic>&#x000a0;lean body mass, <italic>BMD</italic>&#x000a0;body mineral density, <italic>BMC</italic>&#x000a0;body mineral content</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec5"><title>Muscle carnosine content</title><p>Muscle carnosine content was assessed in vivo by 1H-MRS using a whole body 3.0-T MRI scanner (Achieva Intera, Philips Best, the Netherlands) and an eight channel knee coil. In brief, the calf muscle of the left leg was centred within the knee coil fixed with pads to avoid leg motion during acquisition. Conventional anatomical T1-weighted magnetic resonance images were obtained in three orthogonal planes to select the voxel position in the gastrocnemius muscle for MRS measurements. Voxel size was 40&#x000a0;mm (I&#x02013;S)&#x000a0;&#x000d7;&#x000a0;30&#x000a0;mm (A&#x02013;P)&#x000a0;&#x000d7;&#x000a0;12&#x000a0;mm (L&#x02013;R). Single-voxel point-resolved spectroscopy sequence (PRESS) with the following parameters was used: repetition time (TR)&#x000a0;=&#x000a0;2,000&#x000a0;ms; echo time (TE)&#x000a0;=&#x000a0;31&#x000a0;ms; number of repetitions&#x000a0;=&#x000a0;256; 2,048 data points; spectral bandwidth of 2,000&#x000a0;Hz. Total acquisition time of the spectrum was 9&#x000a0;min. Spectra raw data were analysed with Java Magnetic Resonance User Interface software (Naressi et al. <xref ref-type="bibr" rid="CR18">2001</xref>). For quantification purposes, only the carnosine H<sub>2</sub> peak at 8.0&#x000a0;ppm was taken into account. Carnosine values were normalized by the internal water content in the voxel, measured from the water unsuppressed reference acquisitions. Water and carnosine signals were quantified using a Hankel&#x02013;Lanczos singular value decomposition (HLSVD) algorithm (Pijnappel et al. <xref ref-type="bibr" rid="CR20">1992</xref>). No corrections for the effect of relaxation times were applied. The coefficient of variation (CV) for muscle carnosine content was 2.5%. Carnosine data were expressed relatively to the water signal. The lack of a carnosine phantom (i.e., external reference) in the current study precluded us to quantify absolute carnosine concentrations.</p></sec><sec id="Sec6"><title>Physical capacity tests</title><p>The participants were required to visit the laboratory on two occasions. At the first visit, subjects performed an incremental test on a motorized treadmill (Centurion 200, Micromed, Brazil). The starting speed was set at 1.5&#x000a0;mph with increments of 0.5&#x000a0;mph every min up to 3.5&#x000a0;mph; then slope increments (2% increase every min) were made until exhaustion. The ventilatory anaerobic threshold (VAT)&#x000a0;and <italic>V</italic>O<sub>2</sub> peak were determined according to previously described criteria (Howley et al. <xref ref-type="bibr" rid="CR13">1995</xref>). In the next session, the subjects performed a constant-load protocol on the treadmill which consisted of a&#x000a0;single repetition square-wave transition from rest to an exercise intensity corresponding to 75% of the difference between VAT&#x000a0;and <italic>V</italic>O<sub>2</sub> peak. This intensity was maintained to the limit of tolerance (TLIM). In both tests, the time-to-exhaustion was assessed as a measure of exercise tolerance. The subjects received strong verbal encouragement to continue as long as possible.</p></sec><sec id="Sec7"><title>Muscle function tests</title><p>Assessment of&#x000a0;muscle function was through &#x0201c;timed-stands&#x0201d; and &#x0201c;timed-up-and-go&#x0201d; tests. The &#x0201c;timed-stands&#x0201d; test (Newcomer et al. <xref ref-type="bibr" rid="CR19">1993</xref>) evaluates the maximum number of stand-ups that a subject can perform from a standard height (i.e., 45&#x000a0;cm) armless chair within 30&#x000a0;s and the &#x0201c;timed-up-and-go&#x0201d; test evaluates the time that subjects required to rise from a standard arm chair, walk to a line on the floor 3&#x000a0;m away, turn, return, and sit down again, which has been previously validated to measure improvements in daily-life activities (Podsiadlo and Richardson <xref ref-type="bibr" rid="CR21">1991</xref>).</p></sec><sec id="Sec8"><title>Quality of life assessment</title><p>The Brazilian version of the Short-Form Health Survey (SF-36) was used to assess quality of life (Ciconelli et al. <xref ref-type="bibr" rid="CR5">1999</xref>). The SF-36 consists of eight subscales: physical functioning, role limitations due to physical health problems (so-called physical role function), bodily pain, general health perceptions, vitality, social role functioning, role limitations due to emotional health problems (so-called emotional role functioning) and mental health. Items were answered according to standardized response choices. Raw scores are transformed to scale scores ranging from 0 to 100, with higher scores indicating better levels of functioning.</p></sec><sec id="Sec9"><title>Food intake assessment</title><p>Food intake was assessed at baseline and after 12&#x000a0;weeks of supplementation by means of three 24&#x000a0;h dietary recalls undertaken on separate days (2&#x000a0;weekdays and 1&#x000a0;weekend day) using a visual aid photo album of real foods. The 24&#x000a0;h dietary recall consists of the listing of foods and beverages consumed during 24&#x000a0;h prior to the recall. Energy and macronutrient intakes were analysed by the Brazilian software DietPro 5.1 (Minas Gerais, Brazil).</p></sec><sec id="Sec10"><title>Blood and urinary parameters</title><p>Blood and urine samples for clinical biochemistry (i.e., liver, muscle, kidney function tests) and haematology were taken at PRE and POST-12 from all subjects.</p></sec><sec id="Sec11"><title>Statistical analysis</title><p>Intention-to-treat analysis was used for each comparison, irrespective of the compliance with the intervention. Shapiro&#x02013;Wilk test revealed normal distribution of the data. Unpaired <italic>t</italic> tests were used to assess relative changes between groups for muscle carnosine and physical capacity parameters. Quality of life data were tested by Wilcoxon test. The remaining variables were tested by a Mixed Model procedure. Pearson correlations were performed between relative changes in muscle carnosine content and performance parameters. Effect sizes (ES) for muscle carnosine and physical capacity parameters were estimated for the posttest assessments using the pooled standard deviation of the two independent samples at POST-12 to determine the practical significance of the present findings. The significance level was previously set at <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05. Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD.</p></sec></sec><sec id="Sec12" sec-type="results"><title>Results</title><p>According to the subjects&#x02019; self-reported compliance on tablet intake, full adherence to the supplementation protocol was achieved. Three patients (two male and one female from the BA group) presented unreliable MRS scans at either PRE or POST-12 and were excluded from all analyses involving muscle carnosine determination, and all correlations. After exclusion of these subjects, baseline values for all measurements remained non-significantly different between the groups. Body mass and body composition (data not shown), and food intake (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>) did not significantly differ within (between Pre and Post) or between groups.<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Food intake at baseline and after 12&#x000a0;weeks following either beta-alanine or placebo supplementation</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="2">Beta-alanine (<italic>n</italic>&#x000a0;=&#x000a0;12)</th><th align="left" colspan="2">Placebo (<italic>n</italic>&#x000a0;=&#x000a0;6)</th></tr><tr><th align="left">PRE</th><th align="left">POST-12</th><th align="left">PRE</th><th align="left">POST-12</th></tr></thead><tbody><tr><td align="left">Energy (kcal/d)</td><td char="&#x000b1;" align="char">2263&#x000a0;&#x000b1;&#x000a0;332</td><td char="&#x000b1;" align="char">2068&#x000a0;&#x000b1;&#x000a0;513</td><td char="&#x000b1;" align="char">2184&#x000a0;&#x000b1;&#x000a0;409</td><td char="&#x000b1;" align="char">2083&#x000a0;&#x000b1;&#x000a0;352</td></tr><tr><td align="left" colspan="5">Carbohydrate</td></tr><tr><td align="left">&#x000a0;% of energy</td><td char="&#x000b1;" align="char">45&#x000a0;&#x000b1;&#x000a0;7</td><td char="&#x000b1;" align="char">44&#x000a0;&#x000b1;&#x000a0;5</td><td char="&#x000b1;" align="char">54&#x000a0;&#x000b1;&#x000a0;5</td><td char="&#x000b1;" align="char">46&#x000a0;&#x000b1;&#x000a0;1</td></tr><tr><td align="left">&#x000a0;g/day</td><td char="&#x000b1;" align="char">257&#x000a0;&#x000b1;&#x000a0;55</td><td char="&#x000b1;" align="char">228&#x000a0;&#x000b1;&#x000a0;51</td><td char="&#x000b1;" align="char">298&#x000a0;&#x000b1;&#x000a0;23</td><td char="&#x000b1;" align="char">238&#x000a0;&#x000b1;&#x000a0;35</td></tr><tr><td align="left" colspan="5">Fat</td></tr><tr><td align="left">&#x000a0;% of energy</td><td char="&#x000b1;" align="char">38&#x000a0;&#x000b1;&#x000a0;5</td><td char="&#x000b1;" align="char">36&#x000a0;&#x000b1;&#x000a0;4</td><td char="&#x000b1;" align="char">31&#x000a0;&#x000b1;&#x000a0;5</td><td char="&#x000b1;" align="char">36&#x000a0;&#x000b1;&#x000a0;1</td></tr><tr><td align="left">&#x000a0;g/day</td><td char="&#x000b1;" align="char">96&#x000a0;&#x000b1;&#x000a0;17</td><td char="&#x000b1;" align="char">83&#x000a0;&#x000b1;&#x000a0;20</td><td char="&#x000b1;" align="char">76&#x000a0;&#x000b1;&#x000a0;26</td><td char="&#x000b1;" align="char">84&#x000a0;&#x000b1;&#x000a0;15</td></tr><tr><td align="left" colspan="5">Protein</td></tr><tr><td align="left">&#x000a0;% of energy</td><td char="&#x000b1;" align="char">16&#x000a0;&#x000b1;&#x000a0;3</td><td char="&#x000b1;" align="char">20&#x000a0;&#x000b1;&#x000a0;3</td><td char="&#x000b1;" align="char">14&#x000a0;&#x000b1;&#x000a0;1</td><td char="&#x000b1;" align="char">18&#x000a0;&#x000b1;&#x000a0;1</td></tr><tr><td align="left">&#x000a0;g/day</td><td char="&#x000b1;" align="char">93&#x000a0;&#x000b1;&#x000a0;25</td><td char="&#x000b1;" align="char">103&#x000a0;&#x000b1;&#x000a0;44</td><td char="&#x000b1;" align="char">77&#x000a0;&#x000b1;&#x000a0;20</td><td char="&#x000b1;" align="char">94&#x000a0;&#x000b1;&#x000a0;19</td></tr></tbody></table><table-wrap-foot><p>Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD. There were no significant differences within or between groups</p><p><italic>PRE</italic>&#x000a0;baseline, <italic>POST-12</italic>&#x000a0;after 12&#x000a0;weeks of beta-alanine or placebo supplementation</p></table-wrap-foot></table-wrap></p><sec id="Sec13"><title>Muscle carnosine content</title><p>A significant increase in muscle carnosine content was shown in the BA group (+85.4%) when compared with the PL group (+7.2%) (<italic>p</italic>&#x000a0;=&#x000a0;0.004; ES: 1.21) (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a, b).<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p><bold>a</bold> Individual data for muscle carnosine content (arbitrary units) at baseline (PRE) and after 12&#x000a0;weeks of beta-alanine supplementation (POST-12). <bold>b</bold> Relative change (%) in muscle carnosine content (from PRE to POST-12). <italic>Asterisk</italic> indicates <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 when compared with the placebo group</p></caption><graphic xlink:href="726_2011_1190_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec14"><title>Physical capacity</title><p>The time-to-exhaustion in the TLIM test was significantly improved (<italic>p</italic>&#x000a0;=&#x000a0;0.05; ES: 1.71) in the BA group (PRE: 5.2&#x000a0;&#x000b1;&#x000a0;1.9, POST-12: 6.6&#x000a0;&#x000b1;&#x000a0;1.7&#x000a0;min; 36.5%) versus the PL group (PRE: 4.4&#x000a0;&#x000b1;&#x000a0;1.1; POST-12: 4.7&#x000a0;&#x000b1;&#x000a0;1.2&#x000a0;min; 8.6%) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>a). Similarly, the time-to-exhaustion in the incremental test was significantly increased (<italic>p</italic>&#x000a0;=&#x000a0;0.04; ES: 1.03) following beta-alanine supplementation (PRE: 11.0&#x000a0;&#x000b1;&#x000a0;2.1; POST-12: 12.1&#x000a0;&#x000b1;&#x000a0;2.1&#x000a0;min; 12.2%) when compared with placebo (PRE: 12.6&#x000a0;&#x000b1;&#x000a0;1.7; POST-12: 12.5&#x000a0;&#x000b1;&#x000a0;1.5&#x000a0;min; 0.1%) (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>b).<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p><bold>a</bold> Relative change (%) in total time of exercise during the TLIM test (TLIM) from baseline to 12&#x000a0;weeks of beta-alanine supplementation. <bold>b</bold> Relative change (%) in time to exhaustion during the incremental test (TTE). <italic>Asterisk</italic> indicates <italic>p</italic>&#x000a0;&#x0003c;&#x000a0;0.05 when compared with the placebo group</p></caption><graphic xlink:href="726_2011_1190_Fig2_HTML" id="MO2"/></fig></p><p>A significant and positive correlation was observed between the relative change in the muscle carnosine content and the relative change in the time-to-exhaustion in the TLIM test (<italic>r</italic>&#x000a0;=&#x000a0;0.62; <italic>p</italic>&#x000a0;=&#x000a0;0.01) and in the incremental test (<italic>r</italic>&#x000a0;=&#x000a0;0.48; <italic>p</italic>&#x000a0;=&#x000a0;0.02). These correlations are illustrated in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>.<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p><bold>a</bold> Correlation between the relative change (%) in the time-to-exhaustion in the TLIM test and the relative change (%) in the muscle carnosine content. <bold>b</bold> Correlation between the relative change (%) in the time-to-exhaustion in the incremental test and the relative change (%) in the muscle carnosine content</p></caption><graphic xlink:href="726_2011_1190_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec15"><title>Muscle function</title><p>No significant within- or between-group changes were observed in the timed-stands test after beta-alanine supplementation (PRE: 16&#x000a0;&#x000b1;&#x000a0;2; POST-12: 17&#x000a0;&#x000b1;&#x000a0;2 repetitions) when compared with the PL group (PRE: 15&#x000a0;&#x000b1;&#x000a0;3; POST-12: 16&#x000a0;&#x000b1;&#x000a0;3 repetitions). Similarly, no significant changes were observed in the timed-up-and-go test after beta-alanine supplementation (PRE: 6.3&#x000a0;&#x000b1;&#x000a0;0.8; POST-12: 6.2&#x000a0;&#x000b1;&#x000a0;1.1&#x000a0;s) when compared with PL group (PRE: 6.3&#x000a0;&#x000b1;&#x000a0;1.2; POST-12: 6.2&#x000a0;&#x000b1;&#x000a0;1.1&#x000a0;s).</p></sec><sec id="Sec16"><title>Quality of life</title><p>No significant changes were observed between groups for quality of life parameters (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>).<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Short Form Health Survey (SF36) data at baseline and after 12&#x000a0;weeks following either beta-alanine or placebo supplementation</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Domain</th><th align="left" colspan="2">Beta-alanine (<italic>n</italic>&#x000a0;=&#x000a0;12)</th><th align="left" colspan="2">Placebo (<italic>n</italic>&#x000a0;=&#x000a0;6)</th></tr><tr><th align="left">PRE</th><th align="left">POST-12</th><th align="left">PRE</th><th align="left">POST-12</th></tr></thead><tbody><tr><td align="left">Physical functioning</td><td char="&#x000b1;" align="char">74&#x000a0;&#x000b1;&#x000a0;9</td><td char="&#x000b1;" align="char">70&#x000a0;&#x000b1;&#x000a0;13</td><td char="&#x000b1;" align="char">61&#x000a0;&#x000b1;&#x000a0;16</td><td char="&#x000b1;" align="char">74&#x000a0;&#x000b1;&#x000a0;7</td></tr><tr><td align="left">Physical role functioning</td><td char="&#x000b1;" align="char">16&#x000a0;&#x000b1;&#x000a0;8</td><td char="&#x000b1;" align="char">18&#x000a0;&#x000b1;&#x000a0;6</td><td char="&#x000b1;" align="char">11&#x000a0;&#x000b1;&#x000a0;9</td><td char="&#x000b1;" align="char">16&#x000a0;&#x000b1;&#x000a0;5</td></tr><tr><td align="left">Bodily pain</td><td char="&#x000b1;" align="char">63&#x000a0;&#x000b1;&#x000a0;18</td><td char="&#x000b1;" align="char">71&#x000a0;&#x000b1;&#x000a0;20</td><td char="&#x000b1;" align="char">59&#x000a0;&#x000b1;&#x000a0;13</td><td char="&#x000b1;" align="char">61&#x000a0;&#x000b1;&#x000a0;20</td></tr><tr><td align="left">General health perceptions</td><td char="&#x000b1;" align="char">77&#x000a0;&#x000b1;&#x000a0;14</td><td char="&#x000b1;" align="char">82&#x000a0;&#x000b1;&#x000a0;11</td><td char="&#x000b1;" align="char">70&#x000a0;&#x000b1;&#x000a0;13</td><td char="&#x000b1;" align="char">72&#x000a0;&#x000b1;&#x000a0;12</td></tr><tr><td align="left">Vitality</td><td char="&#x000b1;" align="char">73&#x000a0;&#x000b1;&#x000a0;11</td><td char="&#x000b1;" align="char">78&#x000a0;&#x000b1;&#x000a0;12</td><td char="&#x000b1;" align="char">59&#x000a0;&#x000b1;&#x000a0;18</td><td char="&#x000b1;" align="char">63&#x000a0;&#x000b1;&#x000a0;17</td></tr><tr><td align="left">Social role functioning</td><td char="&#x000b1;" align="char">89&#x000a0;&#x000b1;&#x000a0;16</td><td char="&#x000b1;" align="char">91&#x000a0;&#x000b1;&#x000a0;15</td><td char="&#x000b1;" align="char">69&#x000a0;&#x000b1;&#x000a0;19</td><td char="&#x000b1;" align="char">73&#x000a0;&#x000b1;&#x000a0;23</td></tr><tr><td align="left">Emotional role functioning</td><td char="&#x000b1;" align="char">21&#x000a0;&#x000b1;&#x000a0;7</td><td char="&#x000b1;" align="char">22&#x000a0;&#x000b1;&#x000a0;2</td><td char="&#x000b1;" align="char">15&#x000a0;&#x000b1;&#x000a0;7</td><td char="&#x000b1;" align="char">14&#x000a0;&#x000b1;&#x000a0;11</td></tr><tr><td align="left">Mental health</td><td char="&#x000b1;" align="char">79&#x000a0;&#x000b1;&#x000a0;15</td><td char="&#x000b1;" align="char">83&#x000a0;&#x000b1;&#x000a0;9</td><td char="&#x000b1;" align="char">75&#x000a0;&#x000b1;&#x000a0;14</td><td char="&#x000b1;" align="char">81&#x000a0;&#x000b1;&#x000a0;16</td></tr></tbody></table><table-wrap-foot><p>Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD. There were no significant differences within or between groups</p><p><italic>PRE</italic>&#x000a0;baseline, <italic>POST-12</italic>&#x000a0;after 12&#x000a0;weeks of beta-alanine or placebo supplementation</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec17"><title>Blood and urinary parameters and side effects</title><p>Laboratory parameters were unchanged after the intervention (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). Additionally, there were no self-reported side effects throughout the course of the study.<table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Biochemical parameters and haematology at baseline and after 12&#x000a0;weeks following either beta-alanine or placebo supplementation</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="2">Beta-alanine (<italic>n</italic>&#x000a0;=&#x000a0;12)</th><th align="left" colspan="2">Placebo (<italic>n</italic>&#x000a0;=&#x000a0;6)</th></tr><tr><th align="left">PRE</th><th align="left">POST-12</th><th align="left">PRE</th><th align="left">POST-12</th></tr></thead><tbody><tr><td align="left">Aldolase (U/L)</td><td char="&#x000b1;" align="char">3.4&#x000a0;&#x000b1;&#x000a0;0.9</td><td char="&#x000b1;" align="char">3.0&#x000a0;&#x000b1;&#x000a0;1.2</td><td char="&#x000b1;" align="char">4.0&#x000a0;&#x000b1;&#x000a0;0.3</td><td char="&#x000b1;" align="char">4.1&#x000a0;&#x000b1;&#x000a0;0.7</td></tr><tr><td align="left">CK (U/L)</td><td char="&#x000b1;" align="char">141.7&#x000a0;&#x000b1;&#x000a0;82.6</td><td char="&#x000b1;" align="char">123.9&#x000a0;&#x000b1;&#x000a0;65.2</td><td char="&#x000b1;" align="char">117.0&#x000a0;&#x000b1;&#x000a0;87.7</td><td char="&#x000b1;" align="char">148.&#x000a0;&#x000b1;&#x000a0;107.0</td></tr><tr><td align="left">ALT (U/L)</td><td char="&#x000b1;" align="char">28.2&#x000a0;&#x000b1;&#x000a0;15.0</td><td char="&#x000b1;" align="char">26.7&#x000a0;&#x000b1;&#x000a0;7.5</td><td char="&#x000b1;" align="char">23.2&#x000a0;&#x000b1;&#x000a0;6.6</td><td char="&#x000b1;" align="char">23.0&#x000a0;&#x000b1;&#x000a0;10.9</td></tr><tr><td align="left">AST (U/L)</td><td char="&#x000b1;" align="char">24.3&#x000a0;&#x000b1;&#x000a0;7.0</td><td char="&#x000b1;" align="char">22.6&#x000a0;&#x000b1;&#x000a0;4.7</td><td char="&#x000b1;" align="char">23.3&#x000a0;&#x000b1;&#x000a0;2.1</td><td char="&#x000b1;" align="char">21.8&#x000a0;&#x000b1;&#x000a0;4.0</td></tr><tr><td align="left">GGT (U/L)</td><td char="&#x000b1;" align="char">29.00&#x000a0;&#x000b1;&#x000a0;8.71</td><td char="&#x000b1;" align="char">28.09&#x000a0;&#x000b1;&#x000a0;7.54</td><td char="&#x000b1;" align="char">17.83&#x000a0;&#x000b1;&#x000a0;5.91</td><td char="&#x000b1;" align="char">15.50&#x000a0;&#x000b1;&#x000a0;5.82</td></tr><tr><td align="left">Total bilirubin (mg/dL)</td><td char="&#x000b1;" align="char">0.7&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">0.6&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">0.6&#x000a0;&#x000b1;&#x000a0;0.1</td><td char="&#x000b1;" align="char">0.6&#x000a0;&#x000b1;&#x000a0;0.2</td></tr><tr><td align="left">Glycemia (mg/dL)</td><td char="&#x000b1;" align="char">109.7&#x000a0;&#x000b1;&#x000a0;15.7</td><td char="&#x000b1;" align="char">114.4&#x000a0;&#x000b1;&#x000a0;17.9</td><td char="&#x000b1;" align="char">89.0&#x000a0;&#x000b1;&#x000a0;9.0</td><td char="&#x000b1;" align="char">95.0&#x000a0;&#x000b1;&#x000a0;8.4</td></tr><tr><td align="left">LDH (U/L)</td><td char="&#x000b1;" align="char">334.4&#x000a0;&#x000b1;&#x000a0;34.4</td><td char="&#x000b1;" align="char">323.2&#x000a0;&#x000b1;&#x000a0;28.9</td><td char="&#x000b1;" align="char">385.0&#x000a0;&#x000b1;&#x000a0;35.7</td><td char="&#x000b1;" align="char">401.7&#x000a0;&#x000b1;&#x000a0;52.3</td></tr><tr><td align="left">Urea (mg/dL)</td><td char="&#x000b1;" align="char">37.58&#x000a0;&#x000b1;&#x000a0;8.13</td><td char="&#x000b1;" align="char">38.45&#x000a0;&#x000b1;&#x000a0;7.09</td><td char="&#x000b1;" align="char">35.67&#x000a0;&#x000b1;&#x000a0;6.77</td><td char="&#x000b1;" align="char">36.67&#x000a0;&#x000b1;&#x000a0;9.46</td></tr><tr><td align="left">Erythrocytes (1&#x000a0;million/mm<sup>3</sup>)</td><td char="&#x000b1;" align="char">4.94&#x000a0;&#x000b1;&#x000a0;0.34</td><td char="&#x000b1;" align="char">4.94&#x000a0;&#x000b1;&#x000a0;0.31</td><td char="&#x000b1;" align="char">4.82&#x000a0;&#x000b1;&#x000a0;0.45</td><td char="&#x000b1;" align="char">4.80&#x000a0;&#x000b1;&#x000a0;0.53</td></tr><tr><td align="left">Haemoglobin (g/dL)</td><td char="&#x000b1;" align="char">15.05&#x000a0;&#x000b1;&#x000a0;1.31</td><td char="&#x000b1;" align="char">14.85&#x000a0;&#x000b1;&#x000a0;1.09</td><td char="&#x000b1;" align="char">15.05&#x000a0;&#x000b1;&#x000a0;0.92</td><td char="&#x000b1;" align="char">14.72&#x000a0;&#x000b1;&#x000a0;1.09</td></tr><tr><td align="left">Haematocrit (%)</td><td char="&#x000b1;" align="char">44.33&#x000a0;&#x000b1;&#x000a0;3.20</td><td char="&#x000b1;" align="char">44.63&#x000a0;&#x000b1;&#x000a0;2.50</td><td char="&#x000b1;" align="char">44.30&#x000a0;&#x000b1;&#x000a0;3.12</td><td char="&#x000b1;" align="char">44.37&#x000a0;&#x000b1;&#x000a0;3.17</td></tr><tr><td align="left">Leukocytes (1,000/mm<sup>3</sup>)</td><td char="&#x000b1;" align="char">7.4&#x000a0;&#x000b1;&#x000a0;1.6</td><td char="&#x000b1;" align="char">7.5&#x000a0;&#x000b1;&#x000a0;2.7</td><td char="&#x000b1;" align="char">6.1&#x000a0;&#x000b1;&#x000a0;1.0</td><td char="&#x000b1;" align="char">6.6&#x000a0;&#x000b1;&#x000a0;1.5</td></tr><tr><td align="left">Neutrophils (1,000/mm<sup>3</sup>)</td><td char="&#x000b1;" align="char">3.9&#x000a0;&#x000b1;&#x000a0;1.2</td><td char="&#x000b1;" align="char">3.7&#x000a0;&#x000b1;&#x000a0;1.5</td><td char="&#x000b1;" align="char">3.0&#x000a0;&#x000b1;&#x000a0;0.6</td><td char="&#x000b1;" align="char">3.7&#x000a0;&#x000b1;&#x000a0;1.5</td></tr><tr><td align="left">Eosinophils (1,000/mm<sup>3</sup>)</td><td char="&#x000b1;" align="char">0.2&#x000a0;&#x000b1;&#x000a0;0.1</td><td char="&#x000b1;" align="char">0.5&#x000a0;&#x000b1;&#x000a0;1.0</td><td char="&#x000b1;" align="char">0.3&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">0.2&#x000a0;&#x000b1;&#x000a0;0.2</td></tr><tr><td align="left">Basophils (1,000/mm<sup>3</sup>)</td><td char="&#x000b1;" align="char">0.01&#x000a0;&#x000b1;&#x000a0;0.03</td><td char="&#x000b1;" align="char">0.02&#x000a0;&#x000b1;&#x000a0;0.04</td><td char="&#x000b1;" align="char">0.02&#x000a0;&#x000b1;&#x000a0;0.04</td><td char="&#x000b1;" align="char">0.02&#x000a0;&#x000b1;&#x000a0;0.04</td></tr><tr><td align="left">Lymphocytes (1,000/mm<sup>3</sup>)</td><td char="&#x000b1;" align="char">2.6&#x000a0;&#x000b1;&#x000a0;0.5</td><td char="&#x000b1;" align="char">2.6&#x000a0;&#x000b1;&#x000a0;0.8</td><td char="&#x000b1;" align="char">2.2&#x000a0;&#x000b1;&#x000a0;0.6</td><td char="&#x000b1;" align="char">2.1&#x000a0;&#x000b1;&#x000a0;0.8</td></tr><tr><td align="left">Monocytes (1,000/mm<sup>3</sup>)</td><td char="&#x000b1;" align="char">0.6&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">0.6&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">0.6&#x000a0;&#x000b1;&#x000a0;0.1</td><td char="&#x000b1;" align="char">0.6&#x000a0;&#x000b1;&#x000a0;0.1</td></tr><tr><td align="left">Platelets (1,000/mm<sup>3</sup>)</td><td char="&#x000b1;" align="char">266.5&#x000a0;&#x000b1;&#x000a0;59.8</td><td char="&#x000b1;" align="char">261.0&#x000a0;&#x000b1;&#x000a0;61.3</td><td char="&#x000b1;" align="char">244.7&#x000a0;&#x000b1;&#x000a0;35.8</td><td char="&#x000b1;" align="char">253.0&#x000a0;&#x000b1;&#x000a0;67.2</td></tr><tr><td align="left">Urinary creatinine (g/L)</td><td char="&#x000b1;" align="char">1.3&#x000a0;&#x000b1;&#x000a0;0.6</td><td char="&#x000b1;" align="char">1.2&#x000a0;&#x000b1;&#x000a0;0.4</td><td char="&#x000b1;" align="char">1.0&#x000a0;&#x000b1;&#x000a0;0.8</td><td char="&#x000b1;" align="char">0.9&#x000a0;&#x000b1;&#x000a0;0.3</td></tr><tr><td align="left">Creatinine (mg/dL)</td><td char="&#x000b1;" align="char">0.9&#x000a0;&#x000b1;&#x000a0;0.2</td><td char="&#x000b1;" align="char">0.9&#x000a0;&#x000b1;&#x000a0;0.1</td><td char="&#x000b1;" align="char">0.9&#x000a0;&#x000b1;&#x000a0;0.1</td><td char="&#x000b1;" align="char">0.83&#x000a0;&#x000b1;&#x000a0;0.2</td></tr><tr><td align="left">Microalbuminuria (mg/L)</td><td char="&#x000b1;" align="char">6.3&#x000a0;&#x000b1;&#x000a0;3.2</td><td char="&#x000b1;" align="char">6.7&#x000a0;&#x000b1;&#x000a0;3.4</td><td char="&#x000b1;" align="char">6.8&#x000a0;&#x000b1;&#x000a0;6.5</td><td char="&#x000b1;" align="char">4.5&#x000a0;&#x000b1;&#x000a0;3.6</td></tr><tr><td align="left">Proteinuria (g/L)</td><td char="&#x000b1;" align="char">0.07&#x000a0;&#x000b1;&#x000a0;0.05</td><td char="&#x000b1;" align="char">0.08&#x000a0;&#x000b1;&#x000a0;0.04</td><td char="&#x000b1;" align="char">0.07&#x000a0;&#x000b1;&#x000a0;0.05</td><td char="&#x000b1;" align="char">0.07&#x000a0;&#x000b1;&#x000a0;0.05</td></tr></tbody></table><table-wrap-foot><p>Data are expressed as mean&#x000a0;&#x000b1;&#x000a0;SD. There were no significant differences within or between groups</p><p><italic>PRE</italic>&#x000a0;baseline, <italic>POST-12</italic>&#x000a0;after 12&#x000a0;weeks of beta-alanine or placebo supplementation, <italic>AST</italic>&#x000a0;aspartate amino transferase, <italic>ALT</italic>&#x000a0;alanine aminotransferase, <italic>LDH</italic>&#x000a0;lactate dehydrogenase, <italic>CK</italic> creatine kinase, <italic>GGT</italic>&#x000a0;glutamyltransferase</p></table-wrap-foot></table-wrap></p></sec></sec><sec id="Sec18" sec-type="discussion"><title>Discussion</title><p>The main and novel finding of the present study is that beta-alanine supplementation is able to increase the muscle carnosine concentration in elderly (60&#x02013;80 yrs) subjects. Importantly, the study also showed compelling evidence indicating that the increase in muscle carnosine was paralleled by an improvement in exercise tolerance with no evidence of any adverse effect. The present data is in accordance with a growing body of evidence obtained in younger subjects suggesting that beta-alanine supplementation results in increased carnosine synthesis in muscle (Harris et al. <xref ref-type="bibr" rid="CR11">2006</xref>; Hill et al. <xref ref-type="bibr" rid="CR12">2007</xref>). The present data further demonstrate that within the age group measured, ageing does not impair intramuscular beta-alanine uptake or intramuscular carnosine synthesis.</p><p>Although one study (Kim <xref ref-type="bibr" rid="CR16">2009</xref>) demonstrated a normal muscle carnosine content in older individuals with glucose intolerance, Tallon et al. (<xref ref-type="bibr" rid="CR28">2007</xref>) reported a 53% reduction in carnosine in type II, but not in type I muscle fibres, in older subjects with osteoarthritis when compared with younger healthy subjects. Similarly Stuerenburg and Kunze (<xref ref-type="bibr" rid="CR27">1999</xref>) reported a significant age-related reduction in skeletal muscle carnosine. These dissonant findings may be explained, at least in part by dietary differences, as the Korean population studied by Kim (<xref ref-type="bibr" rid="CR16">2009</xref>) is described as eating a typical Korean diet including chicken, pork and beef meat, as well as fish. As noted by Kim (<xref ref-type="bibr" rid="CR16">2009</xref>) Korean cooking is typically done &#x0201c;in the pot&#x0201d; or by barbeque with the result that loss of dipeptides is minimal. Changing dietary patterns in the elderly due to loss of appetite will reduce beta-alanine intake from the ingestion of histidine containing dipeptides (carnosine, anserine and balenine). Even where dietary intake of protein may be adequate, dietary levels of beta-alanine may fall. Declining levels of carnosine in muscle may also occur with preferential loss of type II muscle fibres with age, or with a reduction in cross sectional area of type II muscle fibres, since in humans these have up to two times the level of carnosine compared to type I (Harris et al. <xref ref-type="bibr" rid="CR10">1998</xref>; Hill et al. <xref ref-type="bibr" rid="CR12">2007</xref>). In such circumstances beta-alanine supplementation could be beneficial in maintaining or even elevating muscle carnosine levels with possible improvements in physical exercise capacity and life quality.</p><p>In the present study the mean increase of 85.4% in muscle carnosine content after 12&#x000a0;weeks beta-alanine supplementation was almost identical to the increase observed after 10&#x000a0;weeks by Hill et al. (<xref ref-type="bibr" rid="CR12">2007</xref>), albeit using a dosing level twice that used in this study. Hill et al. (<xref ref-type="bibr" rid="CR12">2007</xref>) administered beta-alanine in a hard gelatin capsule, which disintegrates rapidly on ingestion and gave rise to a peak in the plasma concentration after 30 to 45&#x000a0;min. In the present study a proprietary sustained-release tablet formulation was used, which for the same dose results in a lower and later peak plasma concentration and reduced urinary loss, but generates the same area-under-the-plasma-concentration curve (Stellingwerff et al. <xref ref-type="bibr" rid="CR24">2011</xref>). By slowing the rate of beta-alanine release, less is excreted in urine with a greater percentage retained for carnosine synthesis in muscle.</p><p>Importantly in the present study changes in TLIM and TTE were positively correlated to the changes in muscle carnosine. Similar correlations have been shown in younger subjects with improved performances in cycling (Hill et al. <xref ref-type="bibr" rid="CR12">2007</xref>) and rowing (Baguet et al. <xref ref-type="bibr" rid="CR3">2010</xref>) tracking the increase in muscle carnosine content with beta-alanine supplementation. Although Stout et al. (<xref ref-type="bibr" rid="CR26">2008</xref>) have earlier shown an improvement in the time to neuromuscular fatigue in the elderly with beta-alanine supplementation, the absence of carnosine measurements did not enable comparison to any increase in the muscle carnosine content. The emerging correlations in the current study, between carnosine increase and exercise performance, are consistent with the role of carnosine as an intramuscular H<sup>+</sup> buffer. In the context of the elderly, those still active in such activities as cycling, skating, mountain climbing, even gardening, as examples of strenuous leisure activities involving bouts of intense isometric and dynamic exercise, are likely to gain both immediate benefits from an increase in muscle carnosine, as well as long-term benefits if the current high level of activity can be extended into more senior years. Whether much less active older people are able to derive a similar level of benefit remains to be shown but many simple tasks, for instance stair climbing, which in earlier years might have been accomplished by aerobic exercise, invoke increasing levels of anaerobic effort as muscle mass progressively declines.</p><p>In the present study there were no improvements in the &#x0201c;timed-stands&#x0201d; and &#x0201c;timed-up-and-go&#x0201d; tests. Although these have previously been validated to measure improvements in daily-life activities (Podsiadlo and Richardson <xref ref-type="bibr" rid="CR21">1991</xref>, Newcomer et al. <xref ref-type="bibr" rid="CR19">1993</xref>) this is based on the study of populations far less active than investigated here. The lack of changes in the quality of life may be due to the fact that subjects were healthy and functional at baseline. A future goal, therefore, should be to study the effects of beta-alanine supplementation in patients who are less active and demonstrate a greater degree of sarcopenia and frailty, and poor quality of life.</p><p>In any decade, whether it is 60+, 70+&#x000a0;or even 90+, there will be a broad spectrum of activity levels set against a background of declining musculo-skeletal function. Moderating the rate of decline would help maintain active participation in leisure activities and independence. Regular exercise involving some form of resistance training is considered the most effective treatment in slowing the progression of sarcopenia (Snijders et al. <xref ref-type="bibr" rid="CR23">2009</xref>; Verdijk et al. <xref ref-type="bibr" rid="CR30">2009a</xref>, <xref ref-type="bibr" rid="CR30">b</xref>). We suggest that beta-alanine supplementation by increasing the capacity for resistance exercise and lessening the fatigue burden associated with this, whether performed as part of a prescriptive training programme, in the course of leisure, or simply as part of normal everyday activities, will encourage prolongation of an active life style in elderly people. This assumption needs to be tested in future studies.</p><p>In conclusion the present study indicates that beta-alanine supplementation is effective in increasing the muscle carnosine content in the elderly (60&#x02013;80&#x000a0;years) with improvements in physical exercise capacity. Benefits in maintaining a high muscle carnosine content may be both immediate and long-term, if this encourages subjects to maintain a more active life. Beta-alanine supplementation possibly represents one of the few evidenced-based dietary interventions which may help delay the decline in muscle function with ageing.</p></sec></body><back><ack><p>The authors would like to thank Natural Alternatives International (NAI) which partially sponsored this study and supplied both beta-alanine (Carnosyn&#x02122;) and placebo tablets. This study was also partially supported by Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo (Grant 2010/11221-0).</p><sec id="d29e1743"><title>Conflict of interest</title><p>Dr John Wise&#x000a0;is a former employee&#x000a0;of NAI and today is a consultant to NAI on scientific affairs. Whilst at the Animal Health Trust, Newmarket,&#x000a0;the Royal Veterinary College, London, and the University of Chichester, Chichester, all in the UK, Professor Roger Harris held research grants for beta-alanine research from UK national funding bodies, and from NAI jointly with colleagues at the Korea National Sport University. Today,&#x000a0;Professor Harris is a named inventor, along with other colleagues from these early studies, on patents owned by NAI describing methods&#x000a0;to increase carnosine levels in muscle using beta-alanine supplements. Professor Harris&#x000a0;today acts as an unpaid consultant to NAI. The other authors have no conflict of interests.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Artioli</surname><given-names>GG</given-names></name><name><surname>Gualano</surname><given-names>B</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Stout</surname><given-names>J</given-names></name><name><surname>Lancha</surname><given-names>AH</given-names><suffix>Jr</suffix></name></person-group><article-title>Role of beta-alanine supplementation on muscle carnosine and exercise performance</article-title><source>Med Sci Sports Exerc</source><year>2010</year><volume>42</volume><issue>6</issue><fpage>1162</fpage><lpage>1173</lpage><pub-id pub-id-type="pmid">20479615</pub-id></mixed-citation></ref><ref id="CR3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baguet</surname><given-names>A</given-names></name><name><surname>Bourgois</surname><given-names>J</given-names></name><name><surname>Vanhee</surname><given-names>L</given-names></name><name><surname>Achten</surname><given-names>E</given-names></name><name><surname>Derave</surname><given-names>W</given-names></name></person-group><article-title>Important role of muscle carnosine in rowing performance</article-title><source>J Appl Physiol</source><year>2010</year><volume>109</volume><issue>4</issue><fpage>1096</fpage><lpage>1101</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00141.2010</pub-id><pub-id pub-id-type="pmid">20671038</pub-id></mixed-citation></ref><ref id="CR5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciconelli</surname><given-names>R</given-names></name><name><surname>Ferraz</surname><given-names>M</given-names></name><name><surname>Santos</surname><given-names>W</given-names></name><name><surname>Mein&#x000e3;o</surname><given-names>I</given-names></name><name><surname>Quaresma</surname><given-names>M</given-names></name></person-group><article-title>Tradu&#x000e7;&#x000e3;o para a l&#x000ed;ngua portuguesa e valida&#x000e7;&#x000e3;o do question&#x000e1;rio gen&#x000e9;rico de avalia&#x000e7;&#x000e3;o de qualidade de vida SF-36 (Brasil SF-36)</article-title><source>Rev Bras Reumatol</source><year>1999</year><volume>39</volume><fpage>143</fpage><lpage>150</lpage></mixed-citation></ref><ref id="CR7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cruz-Jentoft</surname><given-names>AJ</given-names></name><name><surname>Baeyens</surname><given-names>JP</given-names></name><name><surname>Bauer</surname><given-names>JM</given-names></name><name><surname>Boirie</surname><given-names>Y</given-names></name><name><surname>Cederholm</surname><given-names>T</given-names></name><name><surname>Landi</surname><given-names>F</given-names></name><name><surname>Martin</surname><given-names>FC</given-names></name><name><surname>Michel</surname><given-names>J-P</given-names></name><name><surname>Rolland</surname><given-names>Y</given-names></name><name><surname>Schneider</surname><given-names>SM</given-names></name><name><surname>Topinkov&#x000e1;</surname><given-names>E</given-names></name><name><surname>Vandewoude</surname><given-names>M</given-names></name><name><surname>Zamboni</surname><given-names>M</given-names></name></person-group><article-title>Sarcopenia: European consensus on definition and diagnosis, report of the European Working Group on sarcopenia in older people</article-title><source>Age Ageing</source><year>2010</year><volume>39</volume><issue>4</issue><fpage>412</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1093/ageing/afq034</pub-id><pub-id pub-id-type="pmid">20392703</pub-id></mixed-citation></ref><ref id="CR8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname><given-names>TJ</given-names></name></person-group><article-title>Invited review: aging and sarcopenia</article-title><source>J Appl Physiol</source><year>2003</year><volume>95</volume><issue>4</issue><fpage>1717</fpage><lpage>1727</lpage><pub-id pub-id-type="pmid">12970377</pub-id></mixed-citation></ref><ref id="CR9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guigoz</surname><given-names>Y</given-names></name><name><surname>Vellas</surname><given-names>B</given-names></name><name><surname>Garry</surname><given-names>P</given-names></name></person-group><article-title>Mini nutritional assessment: a practical assessment tool for grading the nutritional state of elderly patients</article-title><source>Facts Res Gerontol</source><year>1994</year><volume>4</volume><issue>Suppl 2</issue><fpage>15</fpage><lpage>59</lpage></mixed-citation></ref><ref id="CR10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>RC</given-names></name><name><surname>Dunnett</surname><given-names>M</given-names></name><name><surname>Greenhaff</surname><given-names>PL</given-names></name></person-group><article-title>Carnosine and taurine contents in individual fibres in human vastus lateralis muscle</article-title><source>J Sports Science</source><year>1998</year><volume>16</volume><fpage>639</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1080/026404198366443</pub-id></mixed-citation></ref><ref id="CR11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>RC</given-names></name><name><surname>Tallon</surname><given-names>MJ</given-names></name><name><surname>Dunnett</surname><given-names>M</given-names></name><name><surname>Boobis</surname><given-names>L</given-names></name><name><surname>Coakley</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Fallowfield</surname><given-names>JL</given-names></name><name><surname>Hill</surname><given-names>CA</given-names></name><name><surname>Sale</surname><given-names>C</given-names></name><name><surname>Wise</surname><given-names>JA</given-names></name></person-group><article-title>The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis</article-title><source>Amino Acids</source><year>2006</year><volume>30</volume><issue>3</issue><fpage>279</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1007/s00726-006-0299-9</pub-id><pub-id pub-id-type="pmid">16554972</pub-id></mixed-citation></ref><ref id="CR12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>CA</given-names></name><name><surname>Harris</surname><given-names>RC</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Harris</surname><given-names>BD</given-names></name><name><surname>Sale</surname><given-names>C</given-names></name><name><surname>Boobis</surname><given-names>LH</given-names></name><name><surname>Kim</surname><given-names>CK</given-names></name><name><surname>Wise</surname><given-names>JA</given-names></name></person-group><article-title>Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity</article-title><source>Amino Acids</source><year>2007</year><volume>32</volume><issue>2</issue><fpage>225</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1007/s00726-006-0364-4</pub-id><pub-id pub-id-type="pmid">16868650</pub-id></mixed-citation></ref><ref id="CR13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howley</surname><given-names>ET</given-names></name><name><surname>Bassett</surname><given-names>DR</given-names><suffix>Jr</suffix></name><name><surname>Welch</surname><given-names>HG</given-names></name></person-group><article-title>Criteria for maximal oxygen uptake: review and commentary</article-title><source>Med Sci Sports Exerc</source><year>1995</year><volume>27</volume><issue>9</issue><fpage>1292</fpage><lpage>1301</lpage><pub-id pub-id-type="pmid">8531628</pub-id></mixed-citation></ref><ref id="CR14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kendrick</surname><given-names>IP</given-names></name><name><surname>Harris</surname><given-names>RC</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>CK</given-names></name><name><surname>Dang</surname><given-names>VH</given-names></name><name><surname>Lam</surname><given-names>TQ</given-names></name><name><surname>Bui</surname><given-names>TT</given-names></name><name><surname>Smith</surname><given-names>M</given-names></name><name><surname>Wise</surname><given-names>JA</given-names></name></person-group><article-title>The effects of 10&#x000a0;weeks of resistance training combined with beta-alanine supplementation on whole body strength, force production, muscular endurance and body composition</article-title><source>Amino Acids</source><year>2008</year><volume>34</volume><issue>4</issue><fpage>547</fpage><lpage>554</lpage><pub-id pub-id-type="doi">10.1007/s00726-007-0008-3</pub-id><pub-id pub-id-type="pmid">18175046</pub-id></mixed-citation></ref><ref id="CR15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kendrick</surname><given-names>IP</given-names></name><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Harris</surname><given-names>RC</given-names></name><name><surname>Kim</surname><given-names>CK</given-names></name><name><surname>Dang</surname><given-names>VH</given-names></name><name><surname>Lam</surname><given-names>TQ</given-names></name><name><surname>Bui</surname><given-names>TT</given-names></name><name><surname>Wise</surname><given-names>JA</given-names></name></person-group><article-title>The effect of 4&#x000a0;weeks beta-alanine supplementation and isokinetic training on carnosine concentrations in type I and II human skeletal muscle fibres</article-title><source>Eur J Appl Physiol</source><year>2009</year><volume>106</volume><issue>1</issue><fpage>131</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1007/s00421-009-0998-5</pub-id><pub-id pub-id-type="pmid">19214556</pub-id></mixed-citation></ref><ref id="CR16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HJ</given-names></name></person-group><article-title>Comparison of the carnosine and taurine contents of vastus lateralis of elderly Korean males, with impaired glucose tolerance, and young elite Korean swimmers</article-title><source>Amino Acids</source><year>2009</year><volume>36</volume><issue>2</issue><fpage>359</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1007/s00726-008-0092-z</pub-id><pub-id pub-id-type="pmid">18414975</pub-id></mixed-citation></ref><ref id="CR17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madureira</surname><given-names>MM</given-names></name><name><surname>Bonf&#x000e1;</surname><given-names>E</given-names></name><name><surname>Takayama</surname><given-names>L</given-names></name><name><surname>Pereira</surname><given-names>RM</given-names></name></person-group><article-title>A 12-month randomized controlled trial of balance training in elderly women with osteoporosis: improvement of quality of life</article-title><source>Maturitas</source><year>2010</year><volume>66</volume><issue>2</issue><fpage>206</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2010.03.009</pub-id><pub-id pub-id-type="pmid">20395080</pub-id></mixed-citation></ref><ref id="CR18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naressi</surname><given-names>A</given-names></name><name><surname>Couturier</surname><given-names>C</given-names></name><name><surname>Devos</surname><given-names>JM</given-names></name><name><surname>Janssen</surname><given-names>M</given-names></name><name><surname>Mangeat</surname><given-names>C</given-names></name><name><surname>Beer</surname><given-names>R</given-names></name><name><surname>Graveron-Demilly</surname><given-names>D</given-names></name></person-group><article-title>Java-based graphical user interface for the MRUI quantitation package</article-title><source>MAGMA</source><year>2001</year><volume>12</volume><issue>2&#x02013;3</issue><fpage>141</fpage><lpage>152</lpage><pub-id pub-id-type="doi">10.1007/BF02668096</pub-id><pub-id pub-id-type="pmid">11390270</pub-id></mixed-citation></ref><ref id="CR19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newcomer</surname><given-names>KL</given-names></name><name><surname>Krug</surname><given-names>HE</given-names></name><name><surname>Mahowald</surname><given-names>ML</given-names></name></person-group><article-title>Validity and reliability of the timed-stands test for patients with rheumatoid arthritis and other chronic diseases</article-title><source>J Rheumatol</source><year>1993</year><volume>20</volume><issue>1</issue><fpage>21</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">8441160</pub-id></mixed-citation></ref><ref id="CR20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pijnappel</surname><given-names>W</given-names></name><name><surname>Boogaart</surname><given-names>A</given-names></name><name><surname>Beer</surname><given-names>R</given-names></name><name><surname>Ormondt</surname><given-names>D</given-names></name></person-group><article-title>SVD-based quantification of magnetic resonance signals</article-title><source>J Magn Reson</source><year>1992</year><volume>97</volume><fpage>122</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.1016/0022-2364(92)90241-X</pub-id></mixed-citation></ref><ref id="CR21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Podsiadlo</surname><given-names>D</given-names></name><name><surname>Richardson</surname><given-names>S</given-names></name></person-group><article-title>The timed &#x0201c;Up &#x00026; Go&#x0201d;: a test of basic functional mobility for frail elderly persons</article-title><source>J Am Geriatr Soc</source><year>1991</year><volume>39</volume><issue>2</issue><fpage>142</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">1991946</pub-id></mixed-citation></ref><ref id="CR22"><mixed-citation publication-type="other">Sale C, Saunders B, Hudson S, Wise JA, Harris RC, Sunderland CD (2011) Effect of beta-alanine plus sodium bicarbonate on high-intensity cycling capacity. Med Sci Sports Exerc doi:10.1249/MSS.0b013e3182188501</mixed-citation></ref><ref id="CR23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snijders</surname><given-names>T</given-names></name><name><surname>Verdijk</surname><given-names>LB</given-names></name><name><surname>Loon</surname><given-names>LJ</given-names></name></person-group><article-title>The impact of sarcopenia and exercise training on skeletal muscle satellite cells</article-title><source>Ageing Res Rev</source><year>2009</year><volume>8</volume><issue>4</issue><fpage>328</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1016/j.arr.2009.05.003</pub-id><pub-id pub-id-type="pmid">19464390</pub-id></mixed-citation></ref><ref id="CR24"><mixed-citation publication-type="other">Stellingwerff T, Decombaz J, Harris RC and Boesch C (2011) Optimizing in vivo dosing and delivery of beta-alanine supplements. Amino Acids (This issue)</mixed-citation></ref><ref id="CR26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stout</surname><given-names>JR</given-names></name><name><surname>Graves</surname><given-names>BS</given-names></name><name><surname>Smith</surname><given-names>AE</given-names></name><name><surname>Hartman</surname><given-names>MJ</given-names></name><name><surname>Cramer</surname><given-names>JT</given-names></name><name><surname>Beck</surname><given-names>TW</given-names></name><name><surname>Harris</surname><given-names>RC</given-names></name></person-group><article-title>The effect of beta-alanine supplementation on neuromuscular fatigue in elderly (55&#x02013;92&#x000a0;years): a double-blind randomized study</article-title><source>J Int Soc Sports Nutr</source><year>2008</year><volume>5</volume><fpage>21</fpage><pub-id pub-id-type="doi">10.1186/1550-2783-5-21</pub-id><pub-id pub-id-type="pmid">18992136</pub-id></mixed-citation></ref><ref id="CR27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuerenburg</surname><given-names>HJ</given-names></name><name><surname>Kunze</surname><given-names>K</given-names></name></person-group><article-title>Concentrations of free carnosine (a putative membrane-protective antioxidant) in human muscle biopsies and rat muscles</article-title><source>Arch Gerontol Geriatr</source><year>1999</year><volume>29</volume><issue>2</issue><fpage>107</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/S0167-4943(99)00020-5</pub-id><pub-id pub-id-type="pmid">15374064</pub-id></mixed-citation></ref><ref id="CR28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tallon</surname><given-names>MJ</given-names></name><name><surname>Harris</surname><given-names>RC</given-names></name><name><surname>Maffulli</surname><given-names>N</given-names></name><name><surname>Tarnopolsky</surname><given-names>MA</given-names></name></person-group><article-title>Carnosine, taurine and enzyme activities of human skeletal muscle fibres from elderly subjects with osteoarthritis and young moderately active subjects</article-title><source>Biogerontology</source><year>2007</year><volume>8</volume><issue>2</issue><fpage>129</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1007/s10522-006-9038-6</pub-id><pub-id pub-id-type="pmid">16967207</pub-id></mixed-citation></ref><ref id="CR29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdijk</surname><given-names>LB</given-names></name><name><surname>Gleeson</surname><given-names>BG</given-names></name><name><surname>Jonkers</surname><given-names>RA</given-names></name><name><surname>Meijer</surname><given-names>K</given-names></name><name><surname>Savelberg</surname><given-names>HH</given-names></name><name><surname>Dendale</surname><given-names>P</given-names></name><name><surname>Loon</surname><given-names>LJ</given-names></name></person-group><article-title>Skeletal muscle hypertrophy following resistance training is accompanied by a fiber type-specific increase in satellite cell content in elderly men</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>2009</year><volume>64</volume><issue>3</issue><fpage>332</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1093/gerona/gln050</pub-id><pub-id pub-id-type="pmid">19196907</pub-id></mixed-citation></ref><ref id="CR30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdijk</surname><given-names>LB</given-names></name><name><surname>Jonkers</surname><given-names>RA</given-names></name><name><surname>Gleeson</surname><given-names>BG</given-names></name><name><surname>Beelen</surname><given-names>M</given-names></name><name><surname>Meijer</surname><given-names>K</given-names></name><name><surname>Savelberg</surname><given-names>HH</given-names></name><name><surname>Wodzig</surname><given-names>WK</given-names></name><name><surname>Dendale</surname><given-names>P</given-names></name><name><surname>Loon</surname><given-names>LJ</given-names></name></person-group><article-title>Protein supplementation before and after exercise does not further augment skeletal muscle hypertrophy after resistance training in elderly men</article-title><source>Am J Clin Nutr</source><year>2009</year><volume>89</volume><issue>2</issue><fpage>608</fpage><lpage>616</lpage><pub-id pub-id-type="doi">10.3945/ajcn.2008.26626</pub-id><pub-id pub-id-type="pmid">19106243</pub-id></mixed-citation></ref><ref id="CR31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdijk</surname><given-names>LB</given-names></name><name><surname>Snijders</surname><given-names>T</given-names></name><name><surname>Beelen</surname><given-names>M</given-names></name><name><surname>Savelberg</surname><given-names>HH</given-names></name><name><surname>Meijer</surname><given-names>K</given-names></name><name><surname>Kuipers</surname><given-names>H</given-names></name><name><surname>Loon</surname><given-names>LJ</given-names></name></person-group><article-title>Characteristics of muscle fiber type are predictive of skeletal muscle mass and strength in elderly men</article-title><source>J Am Geriatr Soc</source><year>2010</year><volume>58</volume><issue>11</issue><fpage>2069</fpage><lpage>2075</lpage><pub-id pub-id-type="doi">10.1111/j.1532-5415.2010.03150.x</pub-id><pub-id pub-id-type="pmid">21054286</pub-id></mixed-citation></ref><ref id="CR32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voorrips</surname><given-names>LE</given-names></name><name><surname>Ravelli</surname><given-names>AC</given-names></name><name><surname>Dongelmans</surname><given-names>PC</given-names></name><name><surname>Deurenberg</surname><given-names>P</given-names></name><name><surname>Staveren</surname><given-names>WA</given-names></name></person-group><article-title>A physical activity questionnaire for the elderly</article-title><source>Med Sci Sports Exerc</source><year>1991</year><volume>23</volume><issue>8</issue><fpage>974</fpage><lpage>979</lpage><pub-id pub-id-type="pmid">1956274</pub-id></mixed-citation></ref></ref-list></back></article>